Representing RDD Pharma in a merger with a Nasdaq traded company

Partners Ofer Ben-Yehuda, Amir Iliescu and Doron Mutai & associates Daniel Kariv, Ofer Filhaber and Roni Lifshitz represented RDD Pharma in a merger transaction of the Nasdaq traded company Innovate Biopharmaceuticals Inc.; the new name of the merged company is 9 Merers Biopharma Inc.

In addition, a third company was also acquired and 22M USD was raised in new financing that was led by Orbimed Advisors, LLC.

Read the full article

Related News

Aerospace & Aviation

MBR Aerospace Hub, Dubai South: Rewarding Opportunities for Aerospace Players

Read More
HIGH TECH

Webinar on demand | Open Source

Read More
Videos

Webinar on Demand | IPOing in Australia and Canada

Read More
Aerospace & Aviation

Israel’s Ministry of Communications Opens the Floodgates to 5.8GHz-based Drones, Adv. Naama Margolis

Read More
HIGH TECH

“There are technology companies on the stock exchange that justify the value – the business […]

Read More
HIGH TECH
TOMORROW’S NEWS FOOD & FOOD SECURITY Banner

Watch: Tomorrow’s News – Food & Food Security

Read More